BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 26339401)

  • 1. Diagnostic value of dual detection of hepatocyte nuclear factor 1 beta (HNF-1β) and napsin A for diagnosing ovarian clear cell carcinoma.
    Li Q; Zeng X; Cheng X; Zhang J; Ji J; Wang J; Xiong K; Qi Q; Huang W
    Int J Clin Exp Pathol; 2015; 8(7):8305-10. PubMed ID: 26339401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic value of combined detection of HNF-1β and Napsin A in the diagnosis of ovarian clear cell carcinoma].
    Wang J; Li Q; Cheng X; Xiong K; Qi Q; Huang W
    Zhonghua Bing Li Xue Za Zhi; 2015 Dec; 44(12):874-8. PubMed ID: 26888504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Application Value of HNF-1β Transcription Factor in the Diagnosis of Ovarian Clear Cell Carcinoma.
    Huang W; Cheng X; Ji J; Zhang J; Li Q
    Int J Gynecol Pathol; 2016 Jan; 35(1):66-71. PubMed ID: 26166716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical Comparison of Ovarian and Uterine Endometrioid Carcinoma, Endometrioid Carcinoma With Clear Cell Change, and Clear Cell Carcinoma.
    Lim D; Ip PP; Cheung AN; Kiyokawa T; Oliva E
    Am J Surg Pathol; 2015 Aug; 39(8):1061-9. PubMed ID: 25871622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of hepatocyte nuclear factor-1β as a diagnostic marker in ovarian carcinomas with clear cells.
    Kao YC; Lin MC; Lin WC; Jeng YM; Mao TL
    Histopathology; 2012 Nov; 61(5):760-8. PubMed ID: 22747504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of IMP3 in 366 cases with ovarian carcinoma of high grade serous, endometrioid and clear cell subtypes.
    Lu L; Wang S; Zhu Q; Qu Y; Gu W; Ning Y; Chen X; Wang Y
    Pathol Res Pract; 2018 Aug; 214(8):1087-1094. PubMed ID: 29866423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of Napsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 279 ovarian tumours.
    Fadare O; Zhao C; Khabele D; Parkash V; Quick CM; Gwin K; Desouki MM
    Pathology; 2015 Feb; 47(2):105-11. PubMed ID: 25551297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor.
    Hoang LN; Han G; McConechy M; Lau S; Chow C; Gilks CB; Huntsman DG; Köbel M; Lee CH
    Histopathology; 2014 Mar; 64(4):585-96. PubMed ID: 24103020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
    Rekhi B; Deodhar KK; Menon S; Maheshwari A; Bajpai J; Ghosh J; Shylasree ST; Gupta S
    APMIS; 2018 Jan; 126(1):45-55. PubMed ID: 29266433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility.
    Fadare O; Desouki MM; Gwin K; Hanley KZ; Jarboe EA; Liang SX; Quick CM; Zheng W; Parkash V; Hecht JL
    Am J Surg Pathol; 2014 Feb; 38(2):189-96. PubMed ID: 24145649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of HNF-1β in cervical carcinomas: an immunohistochemical study of 155 cases.
    Němejcová K; Cibula D; Dundr P
    Diagn Pathol; 2015 Mar; 10():8. PubMed ID: 25884453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium.
    Iwamoto M; Nakatani Y; Fugo K; Kishimoto T; Kiyokawa T
    Hum Pathol; 2015 Jul; 46(7):957-62. PubMed ID: 25971546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Immunohistochemical Markers (HNF-1β, Napsin A, ER, CTH, and ASS1) to Distinguish Endometrial Clear Cell Carcinoma From Its Morphologic Mimics Including Arias-Stella Reaction.
    Ji JX; Cochrane DR; Tessier-Cloutier B; Leung S; Cheng AS; Chow C; Gilks B; Huntsman DG; Hoang LN
    Int J Gynecol Pathol; 2020 Jul; 39(4):344-353. PubMed ID: 31094885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Napsin A, Hepatocyte Nuclear Factor-1-Beta (HNF-1β), Estrogen and Progesterone Receptors Expression in Arias-Stella Reaction.
    Ip PPC; Wang SY; Wong OGW; Chow KL; Lee HH; Cheung ANY; Tse KY
    Am J Surg Pathol; 2019 Mar; 43(3):325-333. PubMed ID: 30608233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lung-restricted marker napsin A is highly expressed in clear cell carcinomas of the ovary.
    Kandalaft PL; Gown AM; Isacson C
    Am J Clin Pathol; 2014 Dec; 142(6):830-6. PubMed ID: 25389337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific expression of hepatocyte nuclear factor-1beta in the ovarian clear cell adenocarcinoma and its application to cytological diagnosis.
    Higashiguchi A; Yamada T; Susumu N; Mori T; Suzuki A; Aoki D; Sakamoto M
    Cancer Sci; 2007 Mar; 98(3):387-91. PubMed ID: 17270029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.
    Moh M; Krings G; Ates D; Aysal A; Kim GE; Rabban JT
    Am J Surg Pathol; 2016 Mar; 40(3):419-32. PubMed ID: 26551622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Napsin-A and AMACR are Superior to HNF-1β in Distinguishing Between Mesonephric Carcinomas and Clear Cell Carcinomas of the Gynecologic Tract.
    Pors J; Segura S; Cheng A; Ji JX; Tessier-Cloutier B; Cochrane D; Fix DJ; Park K; Gilks B; Hoang L
    Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):593-601. PubMed ID: 31361605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases.
    DeLair D; Oliva E; Köbel M; Macias A; Gilks CB; Soslow RA
    Am J Surg Pathol; 2011 Jan; 35(1):36-44. PubMed ID: 21164285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HNF-1β in ovarian carcinomas with serous and clear cell change.
    DeLair D; Han G; Irving JA; Leung S; Ewanowich CA; Longacre TA; Gilks CB; Soslow RA
    Int J Gynecol Pathol; 2013 Nov; 32(6):541-6. PubMed ID: 24071869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.